Milestone Scientific (MLSS) News Today $0.96 +0.04 (+4.63%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$0.94 -0.01 (-1.29%) As of 04/15/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025April 15 at 6:36 PM | markets.businessinsider.comStockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)StockNews.com began coverage on Milestone Scientific in a research note on Tuesday. They issued a "hold" rating for the company.April 9, 2025 | marketbeat.comMilestone Scientific expands CompuFlo Epidural System footprint with InfiniSurgApril 2, 2025 | finance.yahoo.comMilestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New JerseyApril 1, 2025 | globenewswire.comMilestone Scientific (NYSE:MLSS) Now Covered by StockNews.comStockNews.com started coverage on shares of Milestone Scientific in a research report on Monday. They set a "hold" rating on the stock.March 31, 2025 | marketbeat.comMilestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.comStockNews.com began coverage on shares of Milestone Scientific in a research report on Saturday. They set a "hold" rating for the company.March 15, 2025 | marketbeat.comMilestone Scientific (NYSE:MLSS) Stock Price Down 4.1% - Here's WhyMilestone Scientific (NYSE:MLSS) Shares Down 4.1% - What's Next?March 14, 2025 | marketbeat.comMilestone Scientific (NYSE:MLSS) Stock Price Up 0.9% - What's Next?Milestone Scientific (NYSE:MLSS) Trading 0.9% Higher - Here's What HappenedFebruary 20, 2025 | marketbeat.comMilestone Scientific announces CompuFlo rollout at Pain Doctors MedicalFebruary 4, 2025 | markets.businessinsider.comMilestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLCFebruary 4, 2025 | globenewswire.comStockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)StockNews.com initiated coverage on Milestone Scientific in a research note on Wednesday. They set a "hold" rating for the company.January 29, 2025 | marketbeat.comMilestone Scientific announces CompuFlo rollout at Advanced Spine and PainJanuary 24, 2025 | markets.businessinsider.comMilestone Scientific rolls out new epidural systemJanuary 24, 2025 | msn.comMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder DhillonJanuary 23, 2025 | globenewswire.comMLSS stock touches 52-week high at $1.28 amid robust annual gainsJanuary 21, 2025 | msn.comMilestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on Milestone Scientific in a research note on Tuesday. They issued a "hold" rating on the stock.January 21, 2025 | marketbeat.comMilestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.comStockNews.com assumed coverage on shares of Milestone Scientific in a report on Monday. They set a "hold" rating for the company.January 13, 2025 | marketbeat.comMilestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on Milestone Scientific in a research note on Saturday. They issued a "hold" rating for the company.December 28, 2024 | marketbeat.comMilestone Scientific Inc. (NYSE:MLSS) Director Sells $15,600.00 in StockDecember 21, 2024 | insidertrades.comMilestone Scientific Inc. (NYSE:MLSS) Director Michael Mcgeehan Sells 20,000 SharesMilestone Scientific Inc. (NYSE:MLSS - Get Free Report) Director Michael Mcgeehan sold 20,000 shares of the company's stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $0.78, for a total transaction of $15,600.00. Following the transaction, the director now owns 575,273 shares of the company's stock, valued at $448,712.94. This represents a 3.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.December 20, 2024 | marketbeat.comMilestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024December 4, 2024 | globenewswire.comMilestone Scientific announces approval on contract for FSSNovember 27, 2024 | markets.businessinsider.comMilestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural SystemNovember 26, 2024 | globenewswire.comMilestone Scientific: Strategic Growth Prospects and Upside Potential Affirm Buy RatingNovember 17, 2024 | markets.businessinsider.comMilestone Scientific Inc. (AMEX:MLSS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comMilestone Scientific, Inc.: Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEONovember 15, 2024 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024November 15, 2024 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024November 15, 2024 | finanznachrichten.deMilestone Scientific CEO Arjan Haverhals to retireNovember 15, 2024 | markets.businessinsider.comMilestone Scientific CEO Arjan Haverhals to retireNovember 15, 2024 | markets.businessinsider.comMilestone Scientific Announces Leadership Transition and Future PlansNovember 15, 2024 | markets.businessinsider.comMilestone Scientific Announces Leadership Transition and Future PlansNovember 15, 2024 | markets.businessinsider.comMilestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024November 14, 2024 | globenewswire.comMilestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEONovember 14, 2024 | globenewswire.comMilestone Scientific Inc (MLSS) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 14, 2024 | finance.yahoo.comMilestone Scientific reports Q3 EPS (14c) vs. (35c) last yearNovember 12, 2024 | markets.businessinsider.comMilestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference CallNovember 12, 2024 | globenewswire.comMilestone Scientific expands commercial rollout of CompuFlo Epidural SystemNovember 2, 2024 | markets.businessinsider.comMilestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty CareNovember 1, 2024 | globenewswire.comMilestone Scientific Inc. (NYSE:MLSS) Director Leonard Osser Sells 107,984 SharesOctober 25, 2024 | insidertrades.comLeonard Osser Sells 107,984 Shares of Milestone Scientific Inc. (NYSE:MLSS) StockMilestone Scientific Inc. (NYSE:MLSS - Get Free Report) Director Leonard Osser sold 107,984 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now owns 4,606,882 shares of the company's stock, valued at $4,284,400.26. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.October 23, 2024 | marketbeat.comMilestone Scientific (AMEX:MLSS) Stock Quotes, Forecast and News SummaryOctober 15, 2024 | benzinga.comBenchmark Initiates Coverage of Milestone Scientific (MLSS) with Speculative Buy RecommendationOctober 11, 2024 | msn.comMilestone Scientific (NYSE:MLSS) Research Coverage Started at BenchmarkBenchmark started coverage on shares of Milestone Scientific in a research report on Thursday. They issued a "speculative buy" rating and a $1.25 target price for the company.October 10, 2024 | marketbeat.comMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medicare Price AssignmentOctober 3, 2024 | globenewswire.comMilestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.comStockNews.com started coverage on Milestone Scientific in a research note on Tuesday. They issued a "hold" rating on the stock.October 1, 2024 | marketbeat.comMilestone Scientific Inc. (NYSE:MLSS) Director Sells $134,817.35 in StockAugust 22, 2024 | insidertrades.comInsider Selling: Milestone Scientific Inc. (NYSE:MLSS) Director Sells 141,913 Shares of StockMilestone Scientific Inc. (NYSE:MLSS - Get Free Report) Director Leonard Osser sold 141,913 shares of Milestone Scientific stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the transaction, the director now directly owns 4,602,506 shares of the company's stock, valued at $4,372,380.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.August 21, 2024 | marketbeat.comHistoric milestone for Polish pace science as they successfully launch Eagleeye satelliteAugust 18, 2024 | yahoo.comMilestone Scientific (NYSE:MLSS) Issues Quarterly Earnings ResultsMilestone Scientific (NYSE:MLSS - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The company had revenue of $1.85 million during the quarter.August 18, 2024 | marketbeat.com Remove Ads Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address MLSS Media Mentions By Week MLSS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MLSS News Sentiment▼0.540.78▲Average Medical News Sentiment MLSS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MLSS Articles This Week▼21▲MLSS Articles Average Week Remove Ads Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pulmonx News ZimVie News Nano-X Imaging News Sanara MedTech News Nevro News AVITA Medical News Nyxoah News Inogen News Electromed News Alpha Tau Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MLSS) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLSS Stock Free MLSS Stock Alerts